Development and external validation of a 90-day mortality prediction model for comatose sepsis patients: impact of cerebrovascular disease and dementia - Report - MDSpire
Advertisement
Development and external validation of a 90-day mortality prediction model for comatose sepsis patients: impact of cerebrovascular disease and dementia
Clinical Report: Mortality Prediction Model for Comatose Sepsis Patients
Overview
This study developed a 90-day mortality prediction model for comatose sepsis patients, identifying cerebrovascular disease and dementia as significant predictors.
Background
Comatose sepsis patients are at a heightened risk of mortality, yet the long-term prognostic factors influencing their outcomes remain inadequately defined. Understanding how neurological comorbidities, such as cerebrovascular disorders and dementia, affect mortality risk is crucial.
Data Highlights
Variable
Odds Ratio (OR)
Age
1.05
Base Excess
0.85
PaO2 (per 10-unit decrease)
1.04
BUN
1.02
INR
3.68
Cerebrovascular Disease
2.60
Dementia
4.64
Key Findings
Ninety-day mortality rate was 22.83% among comatose sepsis patients.
Cerebrovascular disease and dementia were identified as strong independent risk factors for mortality.
Glasgow Coma Scale (GCS) was not a significant independent predictor in the final model.
Lower GCS scores correlated with higher mortality in patients without cerebrovascular disease or dementia.
The model achieved a C-index of 0.81, outperforming SOFA, APACHE II, and SAPS II.
External validation confirmed good transportability with a C-index of 0.75.
Clinical Implications
The findings highlight the importance of considering neurological comorbidities when assessing mortality risk in comatose sepsis patients.
Conclusion
Cerebrovascular disease and dementia are strong predictors of 90-day mortality and significantly modulate GCS prognostic value.
Brazilian pediatric intensive care unit study found underweight status was associated with respiratory complications, longer hospitalization, and mortality among critically ill patients with COVID-19.
Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.